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Key summary points
Aim The aim was to investigate the association of severity of neuropsychiatric symptoms and health-related quality of life 
and their interaction with dementia severity among institutionalized older people with dementia.
Findings Neuropsychiatric symptom burden was associated with higher health-related quality of life in residents with severe 
dementia, whereas among those residents with mild–moderate dementia this association was not seen. Very low functional 
capacity was linked to both low number of neuropsychiatric symptoms and low health-related quality of life among those 
with severe dementia.
Message In severe dementia, higher neuropsychiatric symptom burden and better health-related quality of life indicate 
better functioning and higher vitality.
Abstract
Purpose The primary focus in long-term care is to maintain quality of life. The aim of this study was to investigate the 
association of severity of neuropsychiatric symptoms (NPS) and health-related quality of life (HRQoL) and their interaction 
with dementia severity among institutionalized older people with dementia.
Methods 352 long-term care residents aged 65 years or over with dementia participated in this cross-sectional study. NPS 
were measured with Neuropsychiatric Inventory (NPI). HRQoL was measured with 15D. Dementia severity was measured 
with Clinical Dementia Rating (CDR).
Results The severity of NPS was significantly associated with better HRQoL in 15D. Residents with severe dementia (CDR 
3) had worse HRQoL than residents with mild–moderate dementia (CDR < 3). There was a significant interaction between 
NPI and CDR (p = 0.037 for NPI, p < 0.001 for CDR, p < 0.001 for interaction). HRQoL correlated positively with all NPS 
subgroups in residents with severe dementia, but in residents with mild–moderate dementia, no significant correlation existed. 
In severe dementia, higher NPI correlated positively with such dimensions of 15D as mobility, vision, eating, speech, excre-
tion, usual activities, mental functions, and vitality, whereas in residents with mild–moderate dementia only with mobility. 
In mild–moderate dementia, NPI correlated negatively with depression, distress and vitality.
Conclusion Dementia severity and NPS burden are important determining factors of HRQoL in long-term care. NPS have 
a distinct impact on HRQoL at different stages of dementia. In severe dementia, higher NPS and better HRQoL indicate 
better functioning and higher vitality.
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Introduction
Dementia is characterized by cognitive decline, loss of 
autonomy in activities of daily living, and neuropsychiatric 
symptoms (NPS), all of which increase the risk of insti-
tutionalization as the disease progresses [1]. NPS among 
long-term care residents are very common. According to 
recent studies, the prevalence is 82–92% in long-term care 
settings [2, 3]. Longitudinal studies have revealed NPS to be 
persistent [4–6]. NPS include agitation, aggression, depres-
sion, anxiety, apathy, delusions, hallucinations, and sleep 
impairment [7]. These symptoms form clusters and four NPS 
subsyndromes: hyperactivity, psychosis, affective symptoms, 
and apathy, have been identified [8]. NPS have been associ-
ated with severity of cognitive impairments and declining 
functional abilities [9]. Several studies have also shown that 
having NPS impairs quality of life [10–16].
The primary focus in long-term care facilities is to 
improve or maintain quality of life. Thus, health-related 
quality of life (HRQoL) has been increasingly recognized 
as an important patient-centered outcome [17]. HRQoL is 
a multidimensional concept that encompasses the physical, 
emotional, and social components associated with illness or 
treatment [18]. Factors affecting HRQoL need to be identi-
fied to improve HRQoL.
Previous studies of NPS in long-term care have concen-
trated on the prevalence of NPS and its associations. So far, 
however, there has been a scarcity of studies focusing on 
the severity of NPS and its various implications [19]. Sever-
ity is important in understanding the burden of a symptom 
to both the resident and care staff [20]. To our knowledge, 
no earlier study has investigated the impact of NPS sever-
ity on HRQoL. Thus, the aim of this study was to deter-
mine whether an association exists between (1) the sever-
ity of NPS or (2) specific NPS subsyndromes and HRQoL, 
and further, (3) whether there is an interaction with NPS, 
HRQoL, and severity of dementia. In addition, we aimed to 
examine the characteristics of residents with the highest NPS 
burden and possible correlations between different dimen-
sions of HRQoL and NPS to advance our understanding of 
factors associated with HRQoL in institutionalized older 
people with dementia.
Methods
Participants
The participants were recruited to this cross-sectional cohort 
study from institutional settings in Helsinki in 2017. The 
study was offered to all 54 nursing homes in Helsinki. Of 
them, the first 18 to volunteer were included. We recruited 
and assessed consecutive participants from each of these 
nursing homes until we reached a targeted sample of 544. 
Residents without dementia were excluded (n = 192). The 
participants with dementia (n = 352) were assessed between 
February 2018 and August 2018.
Measures
Data on demographic factors (age, sex, and education), 
diagnoses, and medication use were collected from medical 
records. We trained study nurses to collect data and perform 
the assessments. One of the researchers (HMR) participated 
and supported the nurses in their assessments. The study 
nurses performed Mini Mental State Examination (MMSE) 
[21] and Clinical Dementia Rating (CDR) [22] to assess the 
severity of dementia. The Charlson Comorbidity Index was 
used to calculate each resident’s burden of comorbidity [23]. 
The nurses used Mini Nutritional Assessment (MNA) [24] to 
assess and grade each resident’s nutritional state and Barthel 
Index [25] for functional evaluation. The phenotypic frailty 
status was defined by modified Fried criteria [26], with four 
criteria as follows: (1) shrinking was based on weight loss of 
≥ 5% in the preceding year, (2) physical weakness was based 
on self-reported or care staff evaluation of difficulty in carry-
ing a grocery bag, (3) exhaustion was based on self-reported 
or care staff evaluation of low energy during the preceding 
4 weeks, (4) physical inactivity was based on the question: 
“Do you/does the resident exercise regularly weekly?” A 
negative response meant physical inactivity. The sum of ful-
filled criteria classified the person as “not frail” (0 criteria), 
“pre-frail” (1–2 criteria), or “frail” (3–4 criteria).
Data on use of medications were retrieved from medical 
records on the assessment day. All medications were classi-
fied using the Anatomical Therapeutic Chemical (ATC) clas-
sification system [27]. Psychotropic medications included 
antipsychotics (N05A), antidepressants (N06A), anxiolytics 
(N05B), and hypnotics and sedatives (N05C). Anticholiner-
gic medications were classified according to the Anticholin-
ergic Risk Scale (ARS) [28], which is a list of commonly 
prescribed medications with anticholinergic potential. The 
use of Alzheimer medication (N06D) included cholinest-
erase inhibitors (N06DA) and/or memantine (N06DX01). 
Only regularly used medications were considered. Medica-
tion use was considered regular if there was a documented 
regular sequence of administration.
HRQoL was assessed using the 15D instrument, which 
is a generic 15-dimensional measure, internationally vali-
dated in various population samples [18]. It correlates well 
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with other HRQoL measures such as SF-36 (RAND-36) 
and EQ-5 [29]. 15D includes the following 15 dimensions: 
mobility, vision, hearing, breathing, sleeping, eating, speech 
(communication), excretion, usual activities, mental func-
tion, discomfort and symptoms, depression, distress, vital-
ity, and sexual activity. Each dimension is divided into five 
levels. The single index score of 0–1 represents the total 
HRQoL. The maximum score is 1 (no problems on any 
dimension) and the minimum score is 0. Usually the 15D 
is filled in by the participant being assessed, but it may also 
be filled in by the interviewer of the participant or his/her 
proxy. In our study, all the participants were interviewed 
by a study nurse and the 15D was filled in by study nurse 
based on the interview and observation of the participant. 
The 15D shows good discriminant validity among various 
aged populations and also prognostic validity [30]. In our 
study, all participants responded to the question about sexu-
ality with “The state of my health makes sexual activity 
almost impossible”. Thus, this question was excluded from 
the partial correlation analysis.
To evaluate NPS, care staff from the long-term care units 
were interviewed by study nurses using the Neuropsychiatric 
Inventory (NPI) [31]. The original NPI includes 10 common 
dementia NPS (delusions, hallucinations, agitation, dys-
phoria, anxiety, euphoria, apathy, disinhibition, irritability, 
aberrant motor behavior). For each symptom, the severity 
is multiplied by the frequency, and the sum score provides 
the total NPI score (range 0 to 120). Subsyndromes of “Psy-
chosis” (delusion, hallucinations), “Hyperactivity” (agita-
tion, euphoria, disinhibition, irritability, aberrant motor 
behavior), “Affective symptoms” (depression and anxiety), 
and “Apathy” (apathy) were calculated separately, as earlier 
described [8]. We grouped the residents according to the 
total score on NPI into three groups: no relevant NPS (NPI 
0–3), low NPS burden (NPI 4–12), and high NPS burden 
(NPI > 12). According to previous studies, a score > 3 is 
taken to indicate the presence of clinically relevant symp-
toms [32–34]. The cutoff point of 12 was chosen as it was 
the median.
Statistics
Data are presented as means with range or standard devi-
ations (SD) or as counts with percentages. Statistical 
significances for the unadjusted hypothesis of linearity 
across categories of NPI levels were evaluated using the 
Cochran–Armitage test for trend and analysis of variance 
with an appropriate contrast. Adjusted hypothesis of linear-
ity (orthogonal polynomial) was evaluated using analysis of 
co-variance (ANCOVA): age, sex, and the Charlson Comor-
bidity Index were added to the model as covariates. In the 
case of violation of the assumptions (e.g. non-normality), a 
bootstrap-type test was used (5000 replications). Adjusted 
correlation (partial) coefficients were calculated by the Pear-
son method with bootstrapped 95% confidence intervals. The 
normality of the variables was tested using the Shapiro–Wilk 
W test. Stata 15.1 (StataCorp LP, College Station, TX, USA) 
was used for the analysis.
Results
The three NPI groups were similar in basic demographic 
characteristics such as age, sex, and education (Table 1). 
Residents’ mean age was 83 years, 80% were women, and 
two in three had less than 8 years of education. The mean 
number of comorbidities according to the Charlson Comor-
bidity Index was 2.1. No significant differences were present 
between the groups in nutrition or frailty status. According 
to the MNA, 68% of the residents were at risk of malnutri-
tion and 81% were pre-frail according to the modified Fried 
Frailty Criteria, and only two residents were robust. Mean 
MMSE was rather low, 6.8. Two in three residents suffered 
from severe dementia (CDR 3). The NPI groups did not dif-
fer in severity of dementia according to MMSE or CDR.
The groups differed significantly in medication use. The 
mean number of medications in the high NPS burden group 
was 8.8, compared with 7.9 in the group with no significant 
NPS. Residents with high NPS burden were also adminis-
tered more often anticholinergics (p < 0.001) and Alzheimer 
medication (p = 0.041). The use of psychotropics was very 
high (85–90%) in all NPI groups. Significant differences 
between the groups were also detected in functional capac-
ity according to Barthel Index and in HRQoL according 
to 15D. The severity of NPS was significantly associated 
with HRQoL in 15D. The mean 15D score was 0.58 in the 
group with no clinically significant NPS, 0.61 in the group 
with low NPS burden, and 0.63 in the group with high NPS 
burden.
Interaction effects of CDR and NPI score on HRQoL
Residents with severe dementia (CDR 3) had worse HRQoL 
than residents with mild–moderate dementia (CDR < 3). 
Residents with severe dementia and with higher NPI score 
had better HRQoL according to 15D than the respective resi-
dents with lower NPI score. In addition, there was a signifi-
cant interaction between NPI and CDR (p = 0.037 for NPI, 
p < 0.001 for CDR, p < 0.001 for interaction adjusted for age, 
sex, and Charlson Comorbidity Index) (Fig. 1). HRQoL was 
worst for residents with severe dementia and low NPI score 
(0–3) and best for residents with mild–moderate dementia 
and low NPI score (0–3).
In residents with severe dementia, HRQoL correlated 
positively with all NPS subgroups. Thus, the higher the 
HRQoL, the more the NPS in each subsyndrome (Fig. 2). 
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In residents with mild–moderate dementia, HRQoL 
was not significantly correlated with any of the NPS 
subsyndromes.
In residents with severe dementia, higher NPI corre-
lated positively with several dimensions of 15D: mobility, 
vision, eating, speech, excretion, usual activities, men-
tal function, and vitality. In residents with mild–mod-
erate dementia, higher NPI correlated positively only 
with mobility. On the other hand, among residents with 
mild–moderate dementia lower NPI score correlated 
with lower levels of distress and depression and vitality. 
Among those with severe dementia, lower NPI score cor-
related with lower level of distress (Fig. 3).
Discussion
Our study found that among institutionalized older people 
both severity of NPS and severity of dementia were sig-
nificant factors determining HRQoL and they had a sig-
nificant interaction. Surprisingly, a higher total NPI score 
was associated with better HRQoL in residents with severe 
dementia, whereas among those residents with mild–mod-
erate dementia this association was not seen. In severe 
dementia, higher HRQoL correlated with higher points in 
all subsyndromes of NPI. In severe dementia, higher score 
in NPI correlated positively with functional dimensions 
Table 1  Characteristics of 
residents grouped by severity 
of neuropsychiatric symptoms 
according to Neuropsychiatric 
Inventory (NPI) total score
1 NPI = Neuropsychiatric Inventory (Cummings et al. [31]); 2Linearity across categories of NPI scores were 
evaluated using the Cochran–Armitage test for trend and analysis of variance with an appropriate contrast; 
3Charlson Comorbidity Index (Charlson et al. [23]); 4Barthel index (Mahoney et al. [25]); 5CDR = Clini-
cal dementia rating (Hughes et  al. [22]); 6MMSE = Mini mental state examination (Folstein et  al. [21]); 
7MNA = Mini nutritional assessment (Guigoz et  al. [24]); 8Frailty phenotype (Perttila et  al. [26]); 
9Antipsychotics (N05A), antidepressants (N06A), anxiolytics (N05B), hypnotics and sedatives (N05C); 
10ARS = Anticholinergic risk scale (Rudolph [28]). 11Cholinesterase inhibitors (N06DA) and/or memantine 
(N06DX01); 12HRQoL = Health-related quality of life (Sintonen et al. [18]); 13Aalten et al. [34]
NPI1 0–3
N = 167
NPI 4–12
N = 181
NPI > 12
N = 184
P for  trend2
Age, mean (SD) 82 (8) 83 (8) 83 (10) 0.50
Women, n (%) 132 (79) 139 (77) 153 (83) 0.31
Education < 8 years, n (%) 62 (37) 68 (38) 79 (43) 0.45
Charlson Comorbidity  Index3, mean (SD) 2.1 (1.3) 2.2 (1.3) 2.0 (1.3) 0.28
Barthel  index4, mean (SD) 21 (24) 26 (23) 33 (25) < 0.001
CDR5, n (%) 0.85
 < 3 63 (38) 63 (35) 67 (36)
 3 104 (62) 118 (65) 117 (64)
MMSE6, mean (SD) 6.8 (8.6) 6.4 (7.4) 6.9 (7.6) 0.89
MNA7, n (%) 0.42
 > 23.5 well nourished 18 (11) 29 (16) 29 (16)
 17–23.5 at risk of malnutrition 115 (70) 117 (66) 123 (69)
 < 17 malnourished 32 (19) 30 (17) 25 (14)
Frailty8, n (%) 0.31
 Pre-frail 128 (78) 149 (84) 150 (82)
 Frail 37 (22) 29 (16) 32 (18)
Number of medications, mean (SD) 7.9 (3.6) 8.8 (3.5) 8.8 (3.8) 0.031
On psychotropic  medication9, n (%) 144 (86) 154 (85) 162 (90) 0.35
On anticholinergic  medication10, n (%) 71 (43) 95 (52) 115 (64) < 0.001
On Alzheimer  medication11, n (%) 62 (37) 82 (45) 87 (48) 0.041
HRQoL on  15D12, mean (SD) 0.577 (0.134) 0.607 (0.119) 0.629 (0.118) < 0.001
NPI total, mean (SD) 0.7 (1.1) 7.9 (2.8) 28.8 (14.1)
NPI  subsyndromes13, mean (SD)
 Psychosis 0.2 (0.6) 1.1 (1.9) 4.8 (6.1)
 Hyperactivity 0.3 (0.7) 4.7 (3.7) 15.6 (9.8)
 Affective 0.2 (0.6) 1.1 (1.9) 5.5 (5.7)
 Apathy 0.1 (0.4) 1.0 (2.3) 2.9 (4.0)
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of 15D (mobility, usual activities, eating, speech, excre-
tion, and mental function) as well as vitality, whereas in 
mild–moderate dementia lower NPI score correlated with 
lower levels of distress and depression as well as vitality.
These findings highlight the importance of both sever-
ity of dementia and burden of NPS in HRQoL. NPS seem 
to have a distinct impact on HRQoL at different stages of 
dementia. Low functional capacity seems to be linked to 
both low number of NPI and low HRQoL among those with 
severe dementia. A possible explanation for these results 
may be that when dementia progresses to a severe stage with 
a high number of disabilities the residents have less capac-
ity to present NPS, leading to a low NPI score but worse 
HRQoL. Several dimensions of 15D measure functioning. 
Therefore, it is understandable that those residents with 
severe dementia and slightly better capabilities of function-
ing score also better in 15D. Interestingly, vitality in severe 
dementia indicated higher NPI score, whereas it was asso-
ciated with lower NPI score in mild–moderate dementia. 
Among residents with mild–moderate dementia, lower NPI 
scores logically correlated with less depression and distress.
Furthermore, in severe dementia higher HRQoL cor-
related positively with all subsyndromes of NPI. In 
Fig. 1  Relationship of total Neuropsychiatric Inventory (NPI) score 
and health-related quality of life (HRQoL) in 15D according to clini-
cal dementia rating (CDR). Adjusted for age, sex, and the Charlson 
Comorbidity Index
Fig. 2  Partial correlation between health-related quality of life 
(HRQoL) (15D) and Neuropsychiatric Inventory (NPI) subsyndromes 
according to clinical dementia rating (CDR). Correlation adjusted for 
age, sex, and the Charlson Comorbidity Index
Fig. 3  Partial correlation between total Neuropsychiatric Inventory 
(NPI) score and dimensions of 15D according to clinical dementia 
rating (CDR). Correlation adjusted for age, sex, and the Charlson 
Comorbidity Index
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mild–moderate dementia, there was no such correlation. Our 
study cohort comprised only 109 long-term care residents 
with mild–moderate dementia, so the results should be inter-
preted with caution for patients in earlier stages of dementia.
NPI scores among our residents were rather low, mean 
NPI total score being 12, but this is consistent with other 
studies from long-term care [4, 15, 35, 36]. Studies of home-
dwelling people with dementia have found higher NPI scores 
[14, 16, 37]. This difference may be partly explained by the 
properties of NPI as an assessment tool. The assessment 
comes from a third-party perspective. The care staff in long-
term care or the caregivers in the case of home-dwelling 
people with dementia may have different perceptions of the 
severity of symptoms encountered [38]. Care staff might 
minimize the burden of symptoms, accepting the behavior as 
part of the dementia disorder and emphasizing their profes-
sionalism in being able to take care of the various symptoms 
of their residents, whereas an informal caregiver might find 
him/herself in a stressful situation without any formal educa-
tion, resulting in the same symptoms causing more distress.
The multiple different instruments used in previous stud-
ies assessing quality of life in people with dementia compli-
cate comparison between studies. Most of these instruments 
are disease specific and measure mainly mood, behavior, 
social relations, and well-being. In our study, we used the 
15D instrument in which various dimensions measure func-
tioning. The generic 15D instrument has been compared 
with the disease-specific QoL-AD and has been reported 
to evaluate different aspects of quality of life, for example 
general health correlated with 15D but not with the QoL-AD 
scores, whereas depressive symptoms correlated inversely 
with QoL-AD but not with 15D [12].
Our study found dementia severity to be a significant fac-
tor determining HRQoL. This is in concordance with two 
systematic reviews that noted a negative association between 
proxy-rated quality of life and dementia severity [39, 40]. 
The association between dementia severity and quality of 
life has also been reported by a recent cross-sectional cohort 
study in long-term care in the Netherlands [15]. In previous 
studies, dementia severity has also been associated with a 
higher prevalence of NPS in both long-term care and home-
dwelling people with dementia [16, 19, 41, 42]. In our data, 
NPS burden was not associated with dementia severity 
according to MMSE or CDR. This difference might be partly 
explained by the different study groups. The participants of 
our study had overall a more severe stage of dementia, the 
mean MMSE being only 6.8.
In our study, a higher NPS burden was associated with 
better HRQoL. This result is contradictory to most previ-
ous studies showing that having NPS impairs quality of life 
[10–16]. To our knowledge, only one earlier study on quality 
of life in nursing home residents found that a higher NPI had 
a positive influence on the course of quality of life [43]. In 
this study, the cognition of the residents was also rather low, 
mean MMSE being 7.1, which is similar to our study popu-
lation. Thus, one explanation for why our results differ from 
most previous ones seems to be partly due to characteristics 
of the study population. The other studies have examined 
earlier stages of dementia and have had less participants with 
severe dementia.
Interestingly, in our study the use of both anticholinergic 
medication and Alzheimer medication was associated with 
a higher severity of NPS. Due to the cross-sectional nature 
of our study, we do not know whether this is due to adverse 
effects of the medication or the fact that the residents using 
these medications had had even more severe symptoms 
before drug initiation. The use of Alzheimer medication is 
very high due to Current Care Guidelines which in Finland 
recommend Alzheimer medication as the first-line drugs for 
NPS. The use of psychotropic medication was alarmingly 
high in all NPI groups, but there was no difference between 
the groups.
Limitations of our study include the cross-sectional 
design, which limits the possibilities of drawing conclusions 
about causal relationships. Care staff rating of residents’ 
HRQoL may also be considered a limitation. However, this 
method was intentionally chosen because of the high preva-
lence of severe dementia, which could have compromised 
self-reporting. It is known from previous research that there 
are differences between caregiver and self-rated quality of 
life [10, 16, 39]. Residents tend to consider their quality 
of life as significantly higher than caregivers. Assessments 
of residents were performed by the member of staff who 
knew each particular resident best in order to increase the 
validity of the data. In addition, 15D can also be rated by a 
proxy [18]. The study population was long-term care resi-
dents with advanced dementia and, therefore, the results 
cannot be generalized to other populations with dementia. 
Even though CDR scale is one of the most well-known and 
well-studied dementia staging instruments, it is however not 
without limitations. CDR score addresses both cognition and 
physical functioning but it may also be influenced by physi-
cal comorbidities. Another limitation is that pain, a possible 
confounder, was not assessed in our study.
An important strength of our study is the large sample 
size and the use of a large number of well-validated vari-
ables. Residents were assessed by well-trained study nurses 
using the same data collection instruments and methodol-
ogy, resulting in high validity of the data. Eighteen of the 
54 nursing homes in Helsinki were included in this study. 
The baseline characteristics and HRQoL measured in 15D 
were similar to those of the total long-term care popula-
tion in Helsinki; thus, our study cohort was representative 
[44]. Another important strength is that, to our knowledge, 
no other study has previously examined the impact of the 
severity of NPS on HRQoL, nor have the interaction effects 
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of dementia severity and NPS on HRQoL been investigated. 
Thus, these results make an important contribution to our 
understanding of the factors associated with HRQoL in insti-
tutionalized older people with dementia.
Conclusions
Severity of NPS and dementia are important determining 
factors of HRQoL. NPS seem to have a distinct impact on 
HRQoL at different stages of dementia. In severe dementia, 
higher NPS and better HRQoL indicate better functioning 
and higher vitality. These results may help clinicians and 
care staff to detect persons with dementia at risk for a lower 
HRQoL. The data are also important for developing per-
sonalized interventions to improve HRQoL in persons with 
dementia in long-term care.
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